This page shows Scotts Miracle Gr (SMG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Scotts Miracle Gr has an operating margin of 10.5%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 53/100, indicating healthy but not exceptional operating efficiency. This is up from 5.9% the prior year.
Scotts Miracle Gr's revenue declined 3.9% year-over-year, from $3.6B to $3.4B. This contraction results in a growth score of 17/100.
Scotts Miracle Gr's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 31/100. The company can meet its near-term obligations, though with limited headroom.
Scotts Miracle Gr has a free cash flow margin of 8.0%, earning a moderate score of 40/100. The company generates positive cash flow after capital investments, but with room for improvement.
Scotts Miracle Gr scores 2.68, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Scotts Miracle Gr passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Scotts Miracle Gr generates $2.56 in operating cash flow ($371.3M OCF vs $145.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Scotts Miracle Gr earns $2.8 in operating income for every $1 of interest expense ($358.6M vs $128.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Scotts Miracle Gr generated $3.4B in revenue in fiscal year 2025. This represents a decrease of 3.9% from the prior year.
Scotts Miracle Gr's EBITDA was $436.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 50.7% from the prior year.
Scotts Miracle Gr generated $273.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 53.1% from the prior year.
Scotts Miracle Gr reported $145.2M in net income in fiscal year 2025. This represents an increase of 516.0% from the prior year.
Scotts Miracle Gr earned $2.47 per diluted share (EPS) in fiscal year 2025. This represents an increase of 504.9% from the prior year.
Scotts Miracle Gr held $32.8M in cash against $2.0B in long-term debt as of fiscal year 2025.
Scotts Miracle Gr paid $2.64 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Scotts Miracle Gr had 58M shares outstanding in fiscal year 2025. This represents an increase of 1.2% from the prior year.
Scotts Miracle Gr's gross margin was 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 6.7 percentage points from the prior year.
Scotts Miracle Gr's operating margin was 10.5% in fiscal year 2025, reflecting core business profitability. This is up 4.6 percentage points from the prior year.
Scotts Miracle Gr's net profit margin was 4.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.2 percentage points from the prior year.
Scotts Miracle Gr invested $34.8M in research and development in fiscal year 2025. This represents an increase of 0.6% from the prior year.
Scotts Miracle Gr spent $18.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 260.8% from the prior year.
Scotts Miracle Gr invested $97.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 16.0% from the prior year.
SMG Income Statement
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $354.4M-70.2% | $1.2B-16.4% | $1.4B+287.6% | $366.6M-69.5% | $1.2B-21.2% | $1.5B+271.7% | $410.4M-63.3% | $1.1B |
| Cost of Revenue | $264.4M-67.2% | $806.3M-6.9% | $865.8M+212.9% | $276.7M-67.5% | $850.6M-13.8% | $986.8M+178.8% | $354.0M-59.8% | $880.1M |
| Gross Profit | $88.7M-76.5% | $378.0M-31.0% | $547.9M+519.1% | $88.5M-75.0% | $354.1M-23.6% | $463.7M+645.5% | $62.2M-69.8% | $205.9M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $106.0M-30.9% | $153.4M-18.5% | $188.3M+65.9% | $113.5M-23.3% | $147.9M-17.2% | $178.7M+55.7% | $114.8M-10.7% | $128.5M |
| Operating Income | -$21.8M-110.1% | $215.0M-37.6% | $344.7M+852.6% | -$45.8M-122.9% | $200.1M-26.5% | $272.1M+675.3% | -$47.3M-161.2% | $77.3M |
| Interest Expense | $27.2M-14.5% | $31.8M-13.1% | $36.6M+8.0% | $33.9M-12.6% | $38.8M-12.0% | $44.1M+3.0% | $42.8M-9.1% | $47.1M |
| Income Tax | -$15.5M-126.6% | $58.2M-30.2% | $83.4M+436.3% | -$24.8M-148.7% | $50.9M-18.3% | $62.3M+284.9% | -$33.7M-506.0% | $8.3M |
| Net Income | -$125.0M-183.8% | $149.1M-31.4% | $217.5M+412.9% | -$69.5M-152.6% | $132.1M-16.1% | $157.5M+295.7% | -$80.5M-284.2% | $43.7M |
| EPS (Diluted) | $-2.16-185.0% | $2.54-31.7% | $3.72+407.4% | $-1.21-153.1% | $2.28-16.8% | $2.74+293.0% | $-1.42-284.4% | $0.77 |
SMG Balance Sheet
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.0B-1.8% | $3.1B-12.6% | $3.5B+11.6% | $3.2B+10.4% | $2.9B-26.8% | $3.9B+5.6% | $3.7B+8.9% | $3.4B |
| Current Assets | $1.3B-2.0% | $1.3B-25.8% | $1.7B+34.5% | $1.3B+31.1% | $980.4M-49.3% | $1.9B+15.1% | $1.7B+20.3% | $1.4B |
| Cash & Equivalents | $8.3M-83.8% | $51.1M+202.4% | $16.9M+196.5% | $5.7M-92.0% | $71.6M+10.0% | $65.1M+526.0% | $10.4M-67.4% | $31.9M |
| Inventory | $846.7M+55.6% | $544.3M-29.6% | $773.2M-8.5% | $844.9M+43.8% | $587.5M-28.7% | $824.3M-29.5% | $1.2B+32.9% | $880.3M |
| Accounts Receivable | $193.8M-66.2% | $573.8M-28.2% | $799.3M+362.0% | $173.0M-2.1% | $176.8M-79.8% | $876.9M+204.9% | $287.6M-5.5% | $304.2M |
| Goodwill | $243.9M0.0% | $243.9M0.0% | $243.9M0.0% | $243.9M0.0% | $243.9M0.0% | $243.9M0.0% | $243.9M0.0% | $243.9M |
| Total Liabilities | $3.5B+8.4% | $3.3B-14.8% | $3.8B+4.9% | $3.6B+11.9% | $3.3B-21.9% | $4.2B+1.8% | $4.1B+11.4% | $3.7B |
| Current Liabilities | $932.4M+16.8% | $798.6M-21.1% | $1.0B+48.1% | $683.8M-8.9% | $750.3M-29.2% | $1.1B+38.8% | $764.1M-1.2% | $773.7M |
| Long-Term Debt | $2.3B+5.3% | $2.1B-14.3% | $2.5B-5.4% | $2.6B+21.3% | $2.2B-21.2% | $2.8B-7.0% | $3.0B+16.1% | $2.6B |
| Total Equity | -$500.6M-192.9% | -$170.9M+41.1% | -$290.1M+39.5% | -$479.5M-22.8% | -$390.6M-55.7% | -$250.9M+34.9% | -$385.4M-44.2% | -$267.3M |
| Retained Earnings | $131.2M-73.0% | $485.2M+29.8% | $373.7M+90.9% | $195.8M-35.5% | $303.8M-38.2% | $491.8M+32.1% | $372.4M-24.1% | $490.9M |
SMG Cash Flow Statement
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$370.4M-181.5% | $454.4M+141.6% | $188.1M+142.2% | -$445.3M-475.8% | $118.5M-61.0% | $304.2M+188.6% | -$343.2M-164.1% | $535.3M |
| Capital Expenditures | $20.0M+18.3% | $16.9M+103.6% | $8.3M-71.7% | $29.3M+76.5% | $16.6M+1.8% | $16.3M-57.0% | $37.9M+99.5% | $19.0M |
| Free Cash Flow | -$390.4M-189.2% | $437.5M+143.3% | $179.8M+137.9% | -$474.6M-565.8% | $101.9M-64.6% | $287.9M+175.5% | -$381.1M-173.8% | $516.3M |
| Investing Cash Flow | -$21.8M+13.8% | -$25.3M-121.9% | -$11.4M+51.1% | -$23.3M-14.2% | -$20.4M-14.0% | -$17.9M+66.4% | -$53.2M-152.1% | -$21.1M |
| Financing Cash Flow | $366.8M+192.6% | -$396.1M-133.3% | -$169.8M-141.6% | $407.7M+232.9% | -$306.8M-32.6% | -$231.4M-161.8% | $374.2M+173.5% | -$509.1M |
| Dividends Paid | $38.3M+2.1% | $37.5M-5.3% | $39.6M+1.0% | $39.2M+4.3% | $37.6M-1.3% | $38.1M+1.9% | $37.4M+0.8% | $37.1M |
| Share Buybacks | $8.3M+8200.0% | $100K-96.3% | $2.7M-82.7% | $15.6M+15500.0% | $100K-94.4% | $1.8M-41.9% | $3.1M | $0 |
SMG Financial Ratios
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.0%-6.8pp | 31.8%-6.7pp | 38.6%+14.4pp | 24.1%-5.3pp | 29.4%-1.0pp | 30.4%+15.2pp | 15.2%-3.3pp | 18.4% |
| Operating Margin | -6.2%-24.3pp | 18.1%-6.2pp | 24.3%+36.8pp | -12.5%-29.1pp | 16.6%-1.2pp | 17.8%+29.4pp | -11.5%-18.4pp | 6.9% |
| Net Margin | -35.3%-47.8pp | 12.6%-2.8pp | 15.3%+34.3pp | -19.0%-29.9pp | 11.0%+0.7pp | 10.3%+29.9pp | -19.6%-23.5pp | 3.9% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 32.4% |
| Return on Assets | -4.1%-8.9pp | 4.8%-1.3pp | 6.2%+8.3pp | -2.2%-6.0pp | 3.8%-0.2pp | 4.0%+6.2pp | -2.2%-3.1pp | 1.0% |
| Current Ratio | 1.35-0.3 | 1.61-0.1 | 1.71-0.2 | 1.88+0.6 | 1.31-0.5 | 1.82-0.4 | 2.20+0.4 | 1.81 |
| Debt-to-Equity | -4.50+8.0 | -12.50-3.9 | -8.59-3.1 | -5.50+0.1 | -5.57+5.4 | -11.00-3.3 | -7.70+1.9 | -9.57 |
| FCF Margin | -110.2%-147.0pp | 36.8%+24.2pp | 12.7%+142.1pp | -129.5%-177.3pp | 47.8%+28.9pp | 18.9%+111.7pp | -92.9%-141.2pp | 48.3% |
Note: Shareholder equity is negative (-$357.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Frequently Asked Questions
What is Scotts Miracle Gr's annual revenue?
Scotts Miracle Gr (SMG) reported $3.4B in total revenue for fiscal year 2025. This represents a -3.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scotts Miracle Gr's revenue growing?
Scotts Miracle Gr (SMG) revenue declined by 3.9% year-over-year, from $3.6B to $3.4B in fiscal year 2025.
Is Scotts Miracle Gr profitable?
Yes, Scotts Miracle Gr (SMG) reported a net income of $145.2M in fiscal year 2025, with a net profit margin of 4.3%.
What is Scotts Miracle Gr's earnings per share (EPS)?
Scotts Miracle Gr (SMG) reported diluted earnings per share of $2.47 for fiscal year 2025. This represents a 504.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Scotts Miracle Gr's EBITDA?
Scotts Miracle Gr (SMG) had EBITDA of $436.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Scotts Miracle Gr have?
As of fiscal year 2025, Scotts Miracle Gr (SMG) had $32.8M in cash and equivalents against $2.0B in long-term debt.
What is Scotts Miracle Gr's gross margin?
Scotts Miracle Gr (SMG) had a gross margin of 30.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scotts Miracle Gr's operating margin?
Scotts Miracle Gr (SMG) had an operating margin of 10.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Scotts Miracle Gr's net profit margin?
Scotts Miracle Gr (SMG) had a net profit margin of 4.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Scotts Miracle Gr pay dividends?
Yes, Scotts Miracle Gr (SMG) paid $2.64 per share in dividends during fiscal year 2025.
What is Scotts Miracle Gr's free cash flow?
Scotts Miracle Gr (SMG) generated $273.9M in free cash flow during fiscal year 2025. This represents a -53.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scotts Miracle Gr's operating cash flow?
Scotts Miracle Gr (SMG) generated $371.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Scotts Miracle Gr's total assets?
Scotts Miracle Gr (SMG) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Scotts Miracle Gr's capital expenditures?
Scotts Miracle Gr (SMG) invested $97.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Scotts Miracle Gr spend on research and development?
Scotts Miracle Gr (SMG) invested $34.8M in research and development during fiscal year 2025.
Does Scotts Miracle Gr buy back shares?
Yes, Scotts Miracle Gr (SMG) spent $18.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Scotts Miracle Gr have outstanding?
Scotts Miracle Gr (SMG) had 58M shares outstanding as of fiscal year 2025.
What is Scotts Miracle Gr's current ratio?
Scotts Miracle Gr (SMG) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.
What is Scotts Miracle Gr's debt-to-equity ratio?
Scotts Miracle Gr (SMG) had a debt-to-equity ratio of -5.73 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scotts Miracle Gr's return on assets (ROA)?
Scotts Miracle Gr (SMG) had a return on assets of 5.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Scotts Miracle Gr's debt-to-equity ratio negative or unusual?
Scotts Miracle Gr (SMG) has negative shareholder equity of -$357.5M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Scotts Miracle Gr's Altman Z-Score?
Scotts Miracle Gr (SMG) has an Altman Z-Score of 2.68, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Scotts Miracle Gr's Piotroski F-Score?
Scotts Miracle Gr (SMG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scotts Miracle Gr's earnings high quality?
Scotts Miracle Gr (SMG) has an earnings quality ratio of 2.56x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Scotts Miracle Gr cover its interest payments?
Scotts Miracle Gr (SMG) has an interest coverage ratio of 2.8x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Scotts Miracle Gr?
Scotts Miracle Gr (SMG) scores 35 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.